W1siziisimnvbxbpbgvkx3rozw1lx2fzc2v0cy9wb2x0ihjlzgvzawduic9wbmcvymxvzy1iyw5uzxiucg5nil1d

Volt attend The Financial Times US Pharma & Biotech Summit May 2021

W1siziisijiwmjevmdqvmtyvmtuvndgvmjqvytrhmthjzmetmzixzs00mzfmlthkogetowq1yjnmmdljymq0l1vtifboyxjtysbhbmqgqmlvdgvjacbzdw1taxquanbnil0swyjwiiwidgh1bwiilci3ntb4nduwiyjdxq

by Charlotte Gurney

Volt are delighted to attend The Financial Times US Pharma & Biotech Summit 5-6th May 2021. Volt's Jonathan Richards, Managing Consultant, Life Sciences - Medical Affairs & Clinical Development Recruitment will be attending the two day summit.

​Volt were proud sponsors in the Financial Times US Pharma and Biotech Summit 2020 and look forward to attending again this year alongside Fortune 100 organizations and world healthcare leaders. View here

Event bio: The FT US Pharma and Biotech Summit is the essential annual event for professionals interested in the latest developments in drug discovery, clinical trials, market access, manufacturing and supply chains. CEOs, thought leaders and policymakers will discuss how the pharma industry is adapting to meet a new set of challenges and opportunities for the post-pandemic era.

Company President’s and CEO speakers:
Pfizer, AztraZeneca, Biogen U.S. Organization, Amgen, Johnson & Johnson, Samsung Bioepis, Moderna, Catalent, ICER, BERG LLC, Otsuka North America, Paragon Biosciences, Astellas Pharma US.